LEP and breast carcinoma: Analysis of breast cancer cells-derived tumors from mice treated with leptin, honokiol or a combination of leptin and honokiol showed higher expression of Med1 and phosphorylated Med1 in tumors from leptin-treated mice in comparison to honokiol-treated mice.